Biblio

Filters: Author is Kuball, Jürgen [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

C

Tilmont R, Yakoub-Agha I, Eikema D-J, Zinger N, Haenel M, Schaap N, Arroyo CHerrera, Schuermans C, Besemer B, Engelhardt M, et al. Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT. Bone Marrow Transplant. 2023.

Ruggeri A, Galimard J-E, Labopin M, Rafii H, Blaise D, Ciceri F, Diez-Martin J-L, Cornelissen J, Chevallier P, Sanchez-Guijo F, et al. Comparison of outcomes after unrelated double-unit cord blood and haploidentical peripheral blood stem cell transplantation in adults with acute myeloid leukemia, a study on behalf of Eurocord and ALWP-EBMT. Transplant Cell Ther. 2022.

Peric Z, Labopin M, Peczynski C, Polge E, Cornelissen J, Carpenter B, Potter M, Malladi R, Byrne J, Schouten H, et al. Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation-a retrospective study by the Acute Leukemia Working Party of EBMT. Bone Marrow Transplant. 2020.

Wensing AMJ, Chabannon C, Kuball J. The connected worlds of stem cell transplantation and HIV. Lancet HIV. 2020.

Battipaglia G, Mooyaart JE, Meyer R, Mohty M, Sadowska-Klasa A, Goloshchapov O, Locatelli F, Styczyński J, Pavlu J, Dybko J, et al. Current use of fecal microbiota transfer in patients with hematologic diseases: a survey on behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT. Bone Marrow Transplant. 2023.

D

Schmid C, Kuball J, Bug G. Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies. J Clin Oncol. 2021:JCO2001719.

Daenen LGM, van der Bruggen J-T, Leguit RJ, van der Wagen LE, van Rhenen A, Wunderink HF, de Witte MA, Bruns AHW, Kuball J. Disseminated nontuberculous mycobacterial infections after allogeneic hematopoietic stem cell transplantation: a risk-based strategy for early diagnosis. Bone Marrow Transplant. 2023.

H

Czerw T, Labopin M, Schmid C, Cornelissen JJ, Chevallier P, Blaise D, Kuball J, Vigouroux S, Garban F, Lioure B, et al. High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelate. Oncotarget. 2016.

I

Thus KA, Boome LTe, Kuball J, Spierings E. Indirectly Recognized HLA-C Mismatches and Their Potential Role in Transplant Outcome. Front Immunol. 2014;5:210.

L

Nagler A, Labopin M, Swoboda R, Kulagin A, Velardi A, Sanz J, Labussière-Wallet H, Potter V, Kuball J, Sica S, et al. Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marr. Bone Marrow Transplant. 2023.

Garderet L, Gras L, Koster L, de Wreede L, Montserrat R, Vincent L, Fenk R, Karunanithi K, Deeren D, Kaufmann M, et al. Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow . Haematologica. 2024.

M

Trento C, Bernardo MEster, Nagler A, Kuçi S, Bornhäuser M, Köhl U, Strunk D, Galleu A, Sanchez-Guijo F, Gaipa G, et al. Manufacturing mesenchymal stromal cells for the treatment of graft-versus-host disease: a survey amongst centers affiliated to the European Group of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2018.

Scheper W, Gründer C, Kuball J. Multifunctional γδ T cells and their receptors for targeted anticancer immunotherapy. Oncoimmunology. 2013;2(5):e23974.

P

Broers AEC, de Jong CN, Bakunina K, Hazenberg MD, Kooy Mvan Marwij, de Groot M, van Gelder M, Kuball J, van der Holt B, Meijer E, et al. Posttransplant Cyclophosphamide for Prevention of Graft-versus-Host Disease: The Prospective Randomized HOVON-96 Trial. Blood Adv. 2022.

S

van Rhijn-Brouwer FCC, Spierings J, van Rhenen A, Kuball J, van Laar JM. Second autologous haematopoietic stem cell transplantation in systemic sclerosis-a case report. Rheumatology (Oxford). 2019.